These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2723957)

  • 41. Cytotoxic-loaded albumin microspheres: a novel approach to regional chemotherapy.
    McArdle CS; Lewi H; Hansell D; Kerr DJ; McKillop J; Willmott N
    Br J Surg; 1988 Feb; 75(2):132-4. PubMed ID: 3349299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative disposition of adriamycin delivered via magnetic albumin microspheres in presence and absence of magnetic field in rats.
    Gupta PK; Hung CT
    Life Sci; 1990; 46(7):471-9. PubMed ID: 2304381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of a syngeneic rat tumor with magnetically responsive albumin microspheres labeled with doxorubicin or protein A.
    Rettenmaier MA; Stratton JA; Berman ML; Senyei A; Widder K; White DB; DiSaia PJ
    Gynecol Oncol; 1987 May; 27(1):34-43. PubMed ID: 3570048
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toxicity of magnetic albumin microspheres bearing adriamycin.
    Ma J; Chen D; Tian Y; Tao K
    J Tongji Med Univ; 2000; 20(3):261-2. PubMed ID: 11215066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adriamycin-loaded albumin microspheres: qualitative assessment of drug incorporation and in vitro release by high-performance liquid chromatography and high-speed multi-diode array spectrophotometric detection.
    Cummings J; Willmott N
    J Chromatogr; 1985 Sep; 343(1):208-12. PubMed ID: 4066856
    [No Abstract]   [Full Text] [Related]  

  • 46. Albumin microspheres as vehicles for the sustained and controlled release of doxorubicin.
    Jones C; Burton MA; Gray BN
    J Pharm Pharmacol; 1989 Dec; 41(12):813-6. PubMed ID: 2576441
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intra-arterial administration of adriamycin-loaded albumin microspheres for locally advanced breast cancer.
    Doughty JC; Anderson JH; Willmott N; McArdle CS
    Postgrad Med J; 1995 Jan; 71(831):47-9. PubMed ID: 7708595
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A modified method for preparation of adriamycin carried by magnetic albumin microspheres.
    Ma J; Chen D; Tian Y
    J Tongji Med Univ; 2001; 21(3):233-5. PubMed ID: 12539586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug targeting using non-magnetic and magnetic albumin-globulin mix microspheres of mefenamic acid.
    Lalla JK; Ahuja PL
    J Microencapsul; 1991; 8(1):37-52. PubMed ID: 1880690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug-carrier property of albumin microspheres in chemotherapy. V. Antitumor effect of microsphere-entrapped adriamycin on liver metastasis of AH 7974 cells in rats.
    Morimoto Y; Sugibayashi K; Kato Y
    Chem Pharm Bull (Tokyo); 1981 May; 29(5):1433-8. PubMed ID: 7296709
    [No Abstract]   [Full Text] [Related]  

  • 51. Enhanced in vivo activity of adriamycin incorporated into controlled release microspheres.
    Jones C; Burton MA; Gray BN
    Br J Cancer; 1989 May; 59(5):743-5. PubMed ID: 2736208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Chemoembolization with microsphere of silicon-adriamycin composite].
    Yanagiya K; Mizutani Y; Okamura D
    Nihon Rinsho; 1989 Jun; 47(6):1373-8. PubMed ID: 2769999
    [No Abstract]   [Full Text] [Related]  

  • 53. Tumor remission in Yoshida sarcoma-bearing rts by selective targeting of magnetic albumin microspheres containing doxorubicin.
    Widder KJ; Morris RM; Poore G; Howard DP; Senyei AE
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):579-81. PubMed ID: 6941258
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparation and evaluation of albumin microspheres and microcapsules containing cisplatin.
    Nishioka Y; Kyotani S; Okamura M; Mori Y; Miyazaki M; Okazaki K; Ohnishi S; Yamamoto Y; Ito K
    Chem Pharm Bull (Tokyo); 1989 May; 37(5):1399-400. PubMed ID: 2630107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Degradation and intrahepatic compatibility of albumin-heparin conjugate microspheres.
    Cremers HF; Wolf RF; Blaauw EH; Schakenraad JM; Lam KH; Nieuwenhuis P; Verrijk R; Kwon G; Bae YH; Kim SW
    Biomaterials; 1994 Jun; 15(8):577-85. PubMed ID: 7948576
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Covalent coupling of doxorubicin in protein microspheres is a major determinant of tumour drug disposition.
    Cummings J; Willmott N; Marley E; Smyth J
    Biochem Pharmacol; 1991 Jun; 41(12):1849-54. PubMed ID: 2039540
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis of adriamycin-coupled polyglutaraldehyde microspheres and evaluation of their cytostatic activity.
    Tokes ZA; Rogers KE; Rembaum A
    Proc Natl Acad Sci U S A; 1982 Mar; 79(6):2026-30. PubMed ID: 6804952
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitation of the release of doxorubicin from colloidal dosage forms using dynamic dialysis.
    Gupta PK; Hung CT; Perrier DG
    J Pharm Sci; 1987 Feb; 76(2):141-5. PubMed ID: 3572752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biomedical applications of magnetic fluids. III. Antitumour effect of magnetic albumin microsphere-entrapped adriamycin on lung metastasis of AH 7974 in rats.
    Sugibayashi K; Okumura M; Morimoto Y
    Biomaterials; 1982 Jul; 3(3):181-6. PubMed ID: 7115862
    [No Abstract]   [Full Text] [Related]  

  • 60. Albumin microspheres: heat and chemical stabilization.
    Yapel AF
    Methods Enzymol; 1985; 112():1-18. PubMed ID: 4046842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.